|
 |
Cancer > ZD6474
The following information is about ZD6474.
ZD6474 Defined
A substance that is being studied as a treatment for cancer. It belongs to the family of drugs called vascular endothelial growth factor-2 (VEGF-2) receptor antagonists.
This definition is in context to Cancer. See more contextual defintions for ZD6474.
ATA Awards More than $400,000 in Research Grants; Research Grants Advance Diagnosis and Treatment of Thyroid Disease
Published October 6, 2008, 6:21 am, Newswise
The American Thyroid Association (ATA), the nation's leading organization in promoting thyroid health and understanding thyroid biology, will award more than $400,000 in research grants to eleven investigators at the 79th Annual Meeting of the ATA in Chicago, Ill. The ATA will also renew four 2007 research grants based on the current status of their research projects. These grants will support ...
Are you looking for additional Cancer > Zd6474 news? Try our new "Zd6474 News Focus" area.
Off-site ZD6474 Links, User Submitted
The following links have been collected through user bookmark submission in the ZD6474 category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.
Sun Nov 26
- ZD6474 and SC-236, a Cox-2 inhibitor: Antitumor activity of ZD6474, a vascular endothelial growth factor-2 and epidermal growth factor receptor small molecule tyrosine kinase inhibitor, in combination with SC-236, a cyclooxygenase -2 inhibitor.
If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > ZD6474. If you would like to find related tags we recommend Tag Patterns > ZD6474
Off-site Zd6474 Research Links
If you still need additional information on Zd6474 then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.
Cancer Topics
Everything you need to know about Cancer
Cancer
If you know the Cancer Term Name use the links below to quickly jump to your desired focus.
Bookmark Us
The On Topic Network
This website is part of The On Topic Network.
Thank You
Cancer.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.
Best Viewed With
License
This work is licensed under Creative Commons.